Urinary Organic Acid Profiling by GC-MS Reveals Distinct Metabolic Signatures for Non-Invasive Diagnosis and Disease Activity Monitoring of Inflammatory Bowel Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27146318 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Emilia Cuencas Barrientos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC…. Hauptthemen laut MEDLINE: Gas Chromatography-Mass Spectrometry, Metabolomics, Crohn Disease, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Agency for the Promotion of Research, Technological Development, Fundación para el Progreso y la Medicina, Especialidad de Inmunología Clínica, FCQ, UNC.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) prevalence is rising rapidly in South America, yet non-invasive diagnostic and monitoring strategies remain inadequate. Urine samples from 30 individuals (10 healthy controls [C], 10 ulcerative colitis [UC] and 10 Crohn’s disease [CD] patients) from a South American cohort were analyzed by gas chromatography–mass spectrometry (GC-MS); metabolomic profiling employed multivariate statistics, pathway enrichment analysis, and receiver operating characteristic (ROC) curve analysis. Profiling of 62 organic acids revealed distinct metabolic patterns across groups: UC patients showed significantly elevated lactic, adipic, glutaric, phosphoric, aconitic, palmitic, 2-hydroxyisobutyric, pyroglutamic, phthalic, azelaic, and glycolic acids relative to controls, with reduced 4-hydroxyphenyllactic acid and trends toward reduction of 3-(3-hydroxyphenyl)propionic and 3-hydroxyphenylacetic acids; CD patients showed elevated 2-hydroxyisovaleric acid. Lactic, glutaric, and palmitic acids were associated with active UC, while glycolic, phosphoric, and adipic acids characterized remission. Pathway analyses indicated alterations in energy and amino acid metabolism. Exploratory multivariate ROC analyses yielded area under the Curve (AUC) values of 0.754 (IBD vs. controls), 0.904 (UC vs. controls), 0.798 (CD vs. controls), and 0.764 (UC vs. CD). These findings identify candidate urinary organic acid biomarkers associated with IBD status and UC disease activity, warranting validation in larger, independent, longitudinal cohorts before non-invasive tools for disease stratification and personalized management of UC and CD can be developed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), U.A. Consejo Nacional de Investigaciones Científicas y Técnicas (CO…
- Servicio de Inmunología, Fundación Para el Progreso de la Medicina, Córdoba X5000EMS, Argentina.
- Servicio de Gastroenterología, Hospital Privado Universitario de Córdoba, Córdoba X5016KEH, Argentina.
- Laboratorio Central, Hospital Privado Universitario de Córdoba, Córdoba X5016KEH, Argentina.
- Metabolómica Lab, Córdoba X5000IUN, Argentina.
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5000HVA, Argentina.
ORCID-Profile: Domingo C Balderramo, Pablo A Romagnoli
Förderung
- National Agency for the Promotion of Research, Technological Development
- Fundación para el Progreso y la Medicina
- Especialidad de Inmunología Clínica, FCQ, UNC
- National Agency for the Promotion of Research, Technological Development and Innovation Fellowship
Zitieren
APA
Cuencas Barrientos, E., Tantucci, L., Cabrera, D., Fernandez, M. L., Fochesato, A., Delgado, A., Correa, S. G., Balderramo, D. C., & Romagnoli, P. A. (2026). Urinary Organic Acid Profiling by GC-MS Reveals Distinct Metabolic Signatures for Non-Invasive Diagnosis and Disease Activity Monitoring of Inflammatory Bowel Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146318
Vancouver
Cuencas Barrientos E, Tantucci L, Cabrera D, Fernandez ML, Fochesato A, Delgado A, et al. Urinary Organic Acid Profiling by GC-MS Reveals Distinct Metabolic Signatures for Non-Invasive Diagnosis and Disease Activity Monitoring of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146318
BibTeX
@article{CuencasBarrientos2026,
author = {Cuencas Barrientos, Emilia and Tantucci, Leonela and Cabrera, Dafne and Fernandez, Marina L and Fochesato, Adriana and Delgado, Andrea and Correa, Silvia G and Balderramo, Domingo C and Romagnoli, Pablo A},
title = {Urinary Organic Acid Profiling by GC-MS Reveals Distinct Metabolic Signatures for Non-Invasive Diagnosis and Disease Activity Monitoring of Inflammatory Bowel Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27146318}
}
EUVIMED